In vitro differences in toddalolactone metabolism in various species and its effect on cytochrome P450 expression

Context Toddalolactone, the main component of Toddalia asiatica (L.) Lam. (Rutaceae), has anticancer, antihypertension, anti-inflammatory, and antifungal activities.Objective This study investigated the metabolic characteristics of toddalolactone.Materials and methods Toddalolactone metabolic stabil...

Full description

Bibliographic Details
Main Authors: Lina Shan, Xianbao Shi, Tingting Hu, Jiayin Hu, Zhe Guo, Yonggui Song, Dan Su, Xiaoyong Zhang
Format: Article
Language:English
Published: Taylor & Francis Group 2022-12-01
Series:Pharmaceutical Biology
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/13880209.2022.2108062
_version_ 1811342501566480384
author Lina Shan
Xianbao Shi
Tingting Hu
Jiayin Hu
Zhe Guo
Yonggui Song
Dan Su
Xiaoyong Zhang
author_facet Lina Shan
Xianbao Shi
Tingting Hu
Jiayin Hu
Zhe Guo
Yonggui Song
Dan Su
Xiaoyong Zhang
author_sort Lina Shan
collection DOAJ
description Context Toddalolactone, the main component of Toddalia asiatica (L.) Lam. (Rutaceae), has anticancer, antihypertension, anti-inflammatory, and antifungal activities.Objective This study investigated the metabolic characteristics of toddalolactone.Materials and methods Toddalolactone metabolic stabilities were investigated by incubating toddalolactone (20 μM) with liver microsomes from humans, rabbits, mice, rats, dogs, minipigs, and monkeys for 0, 30, 60, and 90 min. The CYP isoforms involved in toddalolactone metabolism were characterized based on chemical inhibition studies and screening assays. The effects of toddalolactone (0, 10, and 50 µM) on CYP1A1 and CYP3A5 protein expression were investigated by immunoblotting. After injecting toddalolactone (10 mg/kg), in vivo pharmacokinetic profiles using six Sprague–Dawley rats were investigated by taking 9-time points, including 0, 0.25, 0.5, 0.75, 1, 2, 4, 6 and 8 h.Results Monkeys showed the greatest metabolic capacity in CYP-mediated and UGT-mediated reaction systems with short half-lives (T1/2) of 245 and 66 min, respectively, while T1/2 of humans in two reaction systems were 673 and 83 min, respectively. CYP1A1 and CYP3A5 were the major CYP isoforms involved in toddalolactone biotransformation. Induction of CYP1A1 protein expression by 50 μM toddalolactone was approximately 50% greater than that of the control (0 μM). Peak plasma concentration (Cmax) for toddalolactone was 0.42 μg/mL, and Tmax occurred at 0.25 h post-dosing. The elimination t1/2 was 1.05 h, and the AUC0–t was 0.46 μg/mL/h.Conclusions These findings demonstrated the significant species differences of toddalolactone metabolic profiles, which will promote appropriate species selection in further toddalolactone studies.
first_indexed 2024-04-13T19:13:34Z
format Article
id doaj.art-3d6e093ec0994beda48894a787d9c4a5
institution Directory Open Access Journal
issn 1388-0209
1744-5116
language English
last_indexed 2024-04-13T19:13:34Z
publishDate 2022-12-01
publisher Taylor & Francis Group
record_format Article
series Pharmaceutical Biology
spelling doaj.art-3d6e093ec0994beda48894a787d9c4a52022-12-22T02:33:46ZengTaylor & Francis GroupPharmaceutical Biology1388-02091744-51162022-12-016011591160510.1080/13880209.2022.2108062In vitro differences in toddalolactone metabolism in various species and its effect on cytochrome P450 expressionLina Shan0Xianbao Shi1Tingting Hu2Jiayin Hu3Zhe Guo4Yonggui Song5Dan Su6Xiaoyong Zhang7The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, ChinaThe First Affiliated Hospital of Jinzhou Medical University, Jinzhou, ChinaThe First Affiliated Hospital of Jinzhou Medical University, Jinzhou, ChinaThe First Affiliated Hospital of Jinzhou Medical University, Jinzhou, ChinaThe First Affiliated Hospital of Jinzhou Medical University, Jinzhou, ChinaJiangxi University of Traditional Chinese Medicine, Nanchang, ChinaJiangxi University of Traditional Chinese Medicine, Nanchang, ChinaThe First Affiliated Hospital of Jinzhou Medical University, Jinzhou, ChinaContext Toddalolactone, the main component of Toddalia asiatica (L.) Lam. (Rutaceae), has anticancer, antihypertension, anti-inflammatory, and antifungal activities.Objective This study investigated the metabolic characteristics of toddalolactone.Materials and methods Toddalolactone metabolic stabilities were investigated by incubating toddalolactone (20 μM) with liver microsomes from humans, rabbits, mice, rats, dogs, minipigs, and monkeys for 0, 30, 60, and 90 min. The CYP isoforms involved in toddalolactone metabolism were characterized based on chemical inhibition studies and screening assays. The effects of toddalolactone (0, 10, and 50 µM) on CYP1A1 and CYP3A5 protein expression were investigated by immunoblotting. After injecting toddalolactone (10 mg/kg), in vivo pharmacokinetic profiles using six Sprague–Dawley rats were investigated by taking 9-time points, including 0, 0.25, 0.5, 0.75, 1, 2, 4, 6 and 8 h.Results Monkeys showed the greatest metabolic capacity in CYP-mediated and UGT-mediated reaction systems with short half-lives (T1/2) of 245 and 66 min, respectively, while T1/2 of humans in two reaction systems were 673 and 83 min, respectively. CYP1A1 and CYP3A5 were the major CYP isoforms involved in toddalolactone biotransformation. Induction of CYP1A1 protein expression by 50 μM toddalolactone was approximately 50% greater than that of the control (0 μM). Peak plasma concentration (Cmax) for toddalolactone was 0.42 μg/mL, and Tmax occurred at 0.25 h post-dosing. The elimination t1/2 was 1.05 h, and the AUC0–t was 0.46 μg/mL/h.Conclusions These findings demonstrated the significant species differences of toddalolactone metabolic profiles, which will promote appropriate species selection in further toddalolactone studies.https://www.tandfonline.com/doi/10.1080/13880209.2022.2108062Liver microsomesspecies differenceenzyme kineticspharmacokineticsLC-MS/MS
spellingShingle Lina Shan
Xianbao Shi
Tingting Hu
Jiayin Hu
Zhe Guo
Yonggui Song
Dan Su
Xiaoyong Zhang
In vitro differences in toddalolactone metabolism in various species and its effect on cytochrome P450 expression
Pharmaceutical Biology
Liver microsomes
species difference
enzyme kinetics
pharmacokinetics
LC-MS/MS
title In vitro differences in toddalolactone metabolism in various species and its effect on cytochrome P450 expression
title_full In vitro differences in toddalolactone metabolism in various species and its effect on cytochrome P450 expression
title_fullStr In vitro differences in toddalolactone metabolism in various species and its effect on cytochrome P450 expression
title_full_unstemmed In vitro differences in toddalolactone metabolism in various species and its effect on cytochrome P450 expression
title_short In vitro differences in toddalolactone metabolism in various species and its effect on cytochrome P450 expression
title_sort in vitro differences in toddalolactone metabolism in various species and its effect on cytochrome p450 expression
topic Liver microsomes
species difference
enzyme kinetics
pharmacokinetics
LC-MS/MS
url https://www.tandfonline.com/doi/10.1080/13880209.2022.2108062
work_keys_str_mv AT linashan invitrodifferencesintoddalolactonemetabolisminvariousspeciesanditseffectoncytochromep450expression
AT xianbaoshi invitrodifferencesintoddalolactonemetabolisminvariousspeciesanditseffectoncytochromep450expression
AT tingtinghu invitrodifferencesintoddalolactonemetabolisminvariousspeciesanditseffectoncytochromep450expression
AT jiayinhu invitrodifferencesintoddalolactonemetabolisminvariousspeciesanditseffectoncytochromep450expression
AT zheguo invitrodifferencesintoddalolactonemetabolisminvariousspeciesanditseffectoncytochromep450expression
AT yongguisong invitrodifferencesintoddalolactonemetabolisminvariousspeciesanditseffectoncytochromep450expression
AT dansu invitrodifferencesintoddalolactonemetabolisminvariousspeciesanditseffectoncytochromep450expression
AT xiaoyongzhang invitrodifferencesintoddalolactonemetabolisminvariousspeciesanditseffectoncytochromep450expression